GEVO vs UTHR · rev $89.4M vs P/E 20, rev $1.56B
Gevo Inc (GEVO) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Gevo Inc (GEVO) is a specialty chemicals company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GEVO revenue for 2026-06-30 was $89.4M. Net income was -$198.6M. GEVO currently screens at market cap $378.5M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
GEVO currently screens at market cap $378.5M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the GEVO and UTHR stock pages for the full models.
Not investment advice.